114 results
Page 3 of 6
6-K/A
EX-99.5
abx485g 4z9i
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
5:24pm
6-K
EX-99.2
f50izji2lt4s0
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
6-K
EX-99.5
cvs3447z3
13 Oct 21
ObsEva Announces Relationship with Syneos Health to Commercialize Linzagolix
9:27am
6-K
EX-99.2
sbwrldzsc mu694
5 Aug 21
Index to Unaudited Condensed Consolidated Financial Statements
6:04am
6-K
EX-99.1
ohy2uw
27 Jul 21
Current report (foreign)
6:12am
6-K
EX-99.2
gqtm9q2yvjpx0qa3f
1 Jun 21
ObsEva SA Announces that Shareholders Approved all Board Proposals at its
6:30am
6-K
EX-99.1
dgz5pok5h2n38hrl
20 May 21
ObsEva Announces Final Results from the Phase 3 PRIMROSE Program of
6:30am
6-K
EX-99.3
ar9wo47r2v 0kdw
6 May 21
Index to Unaudited Condensed Consolidated Financial Statements
6:03am
6-K
EX-99.2
hh0wfco
6 May 21
Index to Unaudited Condensed Consolidated Financial Statements
6:03am
6-K
EX-99.1
h6rg0dvuka 7j4qge
6 May 21
Index to Unaudited Condensed Consolidated Financial Statements
6:03am
6-K
EX-99.1
h9hu52l27ri88lmv88ib
31 Mar 21
Current report (foreign)
7:15am
6-K
EX-1.1
uii1sn
5 Mar 21
Current report (foreign)
8:15am
424B5
916hv
5 Mar 21
Prospectus supplement for primary offering
7:55am
6-K
EX-99.1
6fzlnw4e42w
5 Mar 21
ObsEva Announces Year End 2020 Financial Results
7:21am
6-K
EX-99.2
feqlwp7dpyrdx4t46a
17 Feb 21
ObsEva to Present at the SVB Leerink 10th Annual Global Healthcare Conference
6:04am
6-K
EX-99.1
nz96tx7u e2d
10 Feb 21
ObsEva Provides Business Outlook for 2021
6:10am
6-K/A
EX-99.1
dzfbumxynylgal432
19 Jan 21
Current report (foreign) (amended)
6:25am